Background Due to significant medical improvements, persons with Down syndrome now live well into adulthood. Consequently, primary care for adults with Down syndrome needs to incorporate routine care with screening for condition-specific comorbidities. This study seeks to evaluate the adherence of primary care physicians to age-and condition-specific preventive care in a cohort of adults with Down syndrome. Methods In this retrospective observational cohort study, preventive screening was evaluated in patients with Down syndrome aged 18-45 years who received primary care in an academic medical centre from 2000 to 2008. Comparisons were made based on the field of patients' primary care providers (Family or Internal Medicine). Results This cohort included 62 patients, median index age = 33 years. Forty per cent of patients received primary care by Family Physicians, with 60% seen by Internal Medicine practices. Patient demographics, comorbidities and overall screening patterns were similar between provider groups. Despite near universal screening for obesity and hypothyroidism, adherence to preventive care recommendations was otherwise inconsistent.
Introduction
Down syndrome is among the most commonly identifiable causes of developmental delay, occurring in an estimated 14.5 per 10 000 live births (Parker et al. 2010) . Largely due to improvements in early medical interventions, increasing numbers of persons with Down syndrome now survive well into adulthood (American Academy of Pediatrics 1996) . Nearly 80% survive into adolescence (Hayes et al. 1997) , with an average life expectancy of nearly 60 years (Glasson et al. 2002) .
Individuals with Down syndrome are at increased risk of developing multiple comorbidities which require regular care by both specialists and primary care physicians. Conditions such as intellectual disability (ID), congenital heart disease, haematologic abnormalities, gastrointestinal atresia, obstructive sleep apnea, and hearing and vision abnormalities are well described in children with Down syndrome (Cooley & Graham 1991; Baum et al. 2008; Bull & the Committee on Genetics 2011). However, the onset of many of these comorbidities is not isolated to early childhood. In addition to conditions that typically accompany the ageing process, adults with Down syndrome can also develop medical conditions directly related to their underlying genetic abnormality. This includes increased incidence of conditions commonly associated with Down syndrome (e.g. hypothyroidism, obesity, and obstructive sleep apnea) (Rubin & Crocker 1989; Cooley & Graham 1991 Rimmer et al. 2011; Steingass et al. 2011) , as well as the development of new comorbidities, such as cardiac valvular abnormalities, 'accelerated aging', and 'early senescence' (Goldhaber et al. 1986 (Goldhaber et al. , 1987 Rubin & Crocker 1989; Geggel et al. 1993; Pueschel et al. 1995; Cohen 1999; Smith 2001; Bittles et al. 2007 ; New York Commissioner's Task Force 2009; Steingass et al. 2011) .
Given the rising incidence and prevalence of medical comorbidities in adults with Down syndrome, there is a tremendous need for preventive screening in this population. The adverse effects of many of these conditions can be ameliorated if discovered and treated in a timely fashion. Several recommendations for preventive health care in adults with Down syndrome have been published in the medical literature with varying levels of consensus (Chicoine and Mcguire 2010; Rubin & Crocker 1989; Pueschel et al. 1995; Cohen 1999; Saenz 1999; Van Allen et al. 1999; Tyler & Edman 2004; Wilson & Cooley 2006; Henderson et al. 2007; Virji-Babul et al. 2007 ; New York Commissioner's Task Force 2009; Bull & the Committee on Genetics 2011; Steingass et al. 2011) . However, few studies exist that evaluate adherence to these guidelines (Fergeson et al. 2009; Maatta et al. 2011; McGrath et al. 2011) . Within paediatric populations, persons with Down syndrome are significantly less likely to have a medical home despite higher unmet medical needs (McGrath et al. 2011) . These discrepancies in care are likely to increase with age (McCabe et al. 2011) and are especially concerning given that persons with the number and type of comorbid conditions as adults with Down syndrome have less capacity to deal with a new physiological 'hit' than many of their unaffected age-matched peers.
The purpose of this study is to evaluate how successful primary care physicians in an academic medical centre were in providing age-, gender-, and Down syndrome-specific preventive care over an 8-year period in a cohort of adults with Down syndrome. Based on our experiences as clinicians at this institution, we hypothesised that primary care services were lacking for adults with Down syndrome. We also hypothesised that there would not be appreciable differences in preventive screening patterns based on the field of primary care.
Methods

Study cohort
Our cohort was identified from administrative data gathered from our university hospital's Central Data Repository, which captures all outpatient, inpatient, and emergency care within our health system. Patients aged 18-45 years were included in the initial cohort if they were seen at our institution at any time between 1 January 2000 and 30 June 2008 with Down syndrome listed within any of the 15 diagnostic fields available for each encounter (n = 252) [International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 758.0] (Bryon & Madge 2001) . Diagnosis of Down syndrome was then confirmed through manual chart review utilising a search engine for free-text documents within the electronic medical record known as the Electronic Medical Record Search Engine (EMERSE) (Hanauer 2006; Hanauer et al. 2009 ). Search terms included the following: 'Down syndrome', 'Down's syndrome', 'Downs syndrome', 'Trisomy 21', 'Tri21' and 'Tri 21'. This resulted in 53 cases without Down syndrome being excluded from our cohort.
Within the Central Data Repository, we then identified all patients (meeting the aforementioned age and date criteria) who had visits coded for the commonly associated Down syndrome comorbidities of congenital heart disease, hypothyroidism, and atlanto-axial instability. Congenital heart disease was identified using ICD-9-CM codes 745-745.9, 746-746.9, 747-747.49 . Patients with hypothyroidism were identified using ICD-9-CM codes 243, 244.3, 244.8, 244.9 . Atlanto-axial instability was identified with ICD-9-CM code 847.0. EMERSE (Hanauer 2006; Hanauer et al. 2009 ) was utilised to identify patients with documented Down syndrome in the electronic medical record with one of the aforementioned comorbidities who had not been previously identified by ICD-9-CM code 758.0 (n = 29). Only patients with documented Down syndrome, verified by the authors upon review of the clinical record, were included in the cohort (n = 228) (Fig. 1) . Through chart review, we then identified which patients in our cohort received primary care services within our institution (n = 73). Patients were assigned to mutually exclusive provider groups based on the specialty of their primary care providers (e.g. Family Medicine, Internal Medicine, Pediatrics, or Internal MedicinePediatrics). Only provider groups with Ն20 patients were included in analysis, which led to the exclusion of the Pediatric and Internal MedicinePediatrics provider groups for a final cohort of 62 patients. The Institutional Review Board in our health system approved the study protocol.
Assessment preventive healthcare domains
Through review of existing preventive healthcare guidelines for adults with Down syndrome within the medical literature, areas of broad consensus for preventive screening were determined to be ageand gender-appropriate health care in addition to regular screening for hypothyroidism, obesity, behavioural, psychiatric or intellectual changes, the development of cardiac valve, vision, dental, or hearing abnormalities, and musculoskeletal changes (Chicoine and Mcguire 2010; Goldhaber et al. 1986 Goldhaber et al. , 1987 Pueschel & Scola 1987; Rubin & Crocker 1989; Cooley & Graham 1991; Stebbens et al. 1991; Yeates 1991; Carey 1992; Geggel et al. 1993; American Academy of Pediatrics 1994 , 2001 Pueschel et al. 1995; Verma et al. 1996; Cohen 1999; Saenz 1999; Van Allen et al. 1999; Feingold & Geggel 2001 Steingass et al. 2011) . Therefore, the following screening domains were chosen for evaluation within our study population: atlanto-axial instability, cardiac abnormalities, dental abnormalities, hearing abnormalities, hypothyroidism, obesity, obstructive sleep apnea, reproductive health care, vision, and a combined measure evaluating psychiatric disorders, behaviour difficulties, or memory regression. Criteria for each of these domains are defined in Table 1 . EMERSE was utilised to identify whether patients had received preventive healthcare screening within these domains at any time prior to the end of the 8.5-year study. Manual chart review was used to identify any missing information and to settle any discrepancies identified within the findings from EMERSE. Data collection was performed by investigators KMJ and LCT. The investigators crosschecked 10% of each other's data abstraction and settled any discrepancies by group consensus through duplicated manual chart review.
Determination of additional variables
The length of time spent in the study cohort was calculated by the number of years each patient was within the ages of 18-45 years during the study time frame (1 January 2000-30 June 2008). Where applicable, the time period was adjusted for date of death. Annualised encounters were calculated through division of their total respective sums by the number of years each patient was in the study. Because of inconsistent documentation of medical insurance for patients in this dataset, insurance source was not included as a variable in this analysis. Complexity levels of congenital heart disease were determined through manual chart review, and were classified as mild, moderate or severe based on criteria published by the American College of Cardiology ( Warnes et al. 2001) .
Assessed for eligibility (n=108,216)
All patients aged 18-45years seen in this health system 1 January 2000-30 June 2008 with chronic and serious illnesses originating in childhood.
Patients with visits coded for Down syndrome (n=252).
Excluded (n=53)
No evidence of Down syndrome upon review of electronic medical record.
Review of medical records (n=14,774) All patients within study frame with visits coded for congenital heart disease, hypothyroidism, or atlanto-axial instability.
Included (n=29) Patients with Down syndrome documented in medical record without a visit coded during study frame.
Final cohort of adults with Down syndrome receiving primary care within this health system (n=62).
Excluded (n=12) Analysis restricted to provider groups with ≥20 patients.
Excluded (n=154)
All patients who did not receive primary care services through this health system.
Total number of adults with Down syndrome receiving primary care within this health system (n=74).
Categorised patients into mutually exclusive provider groups based on specialty of primary care provider:
Total number of adults with Down syndrome within health system (n=228). 
Results
Sample characteristics
We identified a total of 62 adults with Down syndrome, aged 18-45 years, who received primary care services at our institution at any time between 1 January 2000 and 30 June 2008. This constituted 372 years of patient data. Members of this cohort were predominantly male (63%) with a median age at index encounter of 33 years ( Table 2) . Only 34% of our cohort were ever hospitalised during the study period; of those hospitalised, less than half had more than one inpatient stay (Fig. 2 ). There were five deaths during the study period, causes not available in the electronic medical record. Nearly all persons in our cohort required some form of subspecialty care, with the median patient accessing two subspecialty providers. Comorbidities were common, the most frequent of which were overweight/obesity (71%), diagnosis of psychiatric disorders, behaviour difficulties or memory regression (52%), poor dentition (55%), and hypothyroidism (45%) ( Table 3 ). Table 3 ). The Internal Medicine and Family Medicine provider groups also displayed similar overall patterns of healthcare utilisation and hospitalisation. Direct comparison of comorbidities between provider groups shows similar prevalence of all conditions evaluated (Table 3) , as well as the presence and severity of congenital heart disease ( Table 4) .
Adherence to screening recommendations
Screening patterns for preventive healthcare domains in adults with Down syndrome were largely similar between the Internal Medicine and Family Medicine provider groups ( Table 5) . Both provider types achieved high levels of adherence in screening for obesity and hypothyroidism (>90% in both domains). Screening was 'moderate' (50-80% adherence) for cardiac anomalies, reproductive health care, poor dentition, and the combined measure of behavioural, psychological, or memory abnormalities. The only areas of discrepancy between provider groups were in reproductive health care (adherence = Family Medicine 72%, Sample diagnoses within each category ( Warnes et al. 2001 ):
• Mild congenital heart disease: isolated patent foramen ovale, isolated small atrial septal defect, isolated small ventricular septal defect without associated lesions;
• Moderate congenital heart disease: anomalous pulmonary venous return, coarctation of the aorta, Ebstein's anomaly, Tetralogy of Fallot, atrioventricular canal defects;
• Severe congenital heart disease: all forms of cyanotic heart disease, double-outlet ventricle, Eisenmenger syndrome, pulmonary atresia, pulmonary vascular obstructive disease.
Internal Medicine 43%, P = 0.03) and in screening for cardiac anomalies (adherence = Internal Medicine 81%, Family Medicine 48%, P = 0.006). Both provider groups demonstrated low adherence (<50%) in screening for obstructive sleep apnea, atlanto-axial instability, hearing loss, and vision abnormalities.
Discussion
As we approached this study, we hypothesised that primary care services at our institution would be insufficient for adults with Down syndrome and that no substantive differences would be observed between primary care provider types. Our findings support these hypotheses. Although few differences were observed in screening behaviours between providers in Internal Medicine and Family Medicine at our institution, it is important to note that overall adherence to existing preventive healthcare recommendations for adults with Down syndrome was inconsistent.
Our providers excelled at screening for obesity and hypothyroidism but demonstrated varying levels of adherence to the remaining preventive care domains. Given that screening needed to occur only once during this 8.5-year study period for patients to receive credit for any given domain, this is especially concerning. Nationally, screening patterns for similar domains in general adult populations demonstrate annual adherence anywhere from 33% for depression screening (Tudiver et al. 2010 ) to 92% for cervical cancer screening (Hughes et al. 2010) . In comparison, 52% of our cohort was screened for the combined measure of psychiatric disorders, behavioural disorders or memory regression, and only 55% of our cohort received reproductive health screening at least once over this 8.5-year study.
The purpose of primary care is to identify conditions for which prevention, early identification, and treatment can decrease an individual's morbidity and mortality (Robertson et al. 2011) . For each of the preventive healthcare domains addressed in this study, early detection and intervention have the potential to make a substantive impact on the lives of persons with Down syndrome. For example, individuals with Down syndrome are at high risk for obesity because of multiple factors, including inactivity and hypothyroidism (Smith 2001; Henderson et al. 2007 ; Bull & the Committee on Genetics 2011; Steingass et al. 2011) . However, they are also at high risk for obstructive sleep apnea independent of obesity, which itself is a known risk factor for obstructive sleep apnea. Interventions that decrease obesity, therefore, can have multiple positive downstream effects. Additionally, poor dentition has been identified as risk factor for increased morbidity (Garcia et al. 1998) , while untreated hearing loss can manifest itself in decreased learning potential, social withdrawal or even clinical depression Hild et al. 2008) .
Recently published work in the geriatric (non-Down syndrome) population indicates that changes in cognitive ability can function as an independent risk factor for mortality (Sachs et al. 2011) . Given the accelerated ageing and early senescence experienced by individuals with Down syndrome (Rubin & Crocker 1989; Pueschel et al. 1995; Smith 2001; Bittles et al. 2007 ; New York Commissioner's Task Force 2009), we anticipate these findings would readily translate into our population that already has a baseline level of ID (Singer & Strauss 1997) .
In addition to screening for Down syndromespecific comorbidities, it is important to ensure both age-and gender-appropriate screening. This includes typical primary care domains such as reproductive health screening, diet, exercise, and primary prevention of general adult conditions, such as cardiovascular disease (Bittles et al. 2007) . The invasive nature of some screening mechanisms must be weighed against each person's ability to undergo such procedures. Nonetheless, these conversations need to occur between providers, patients and their caregivers. Informed decisions need to be made regarding whether traditional screening methods can be utilised or whether alternative, less invasive procedures may be used to approximate care that might not otherwise have been provided (e.g. fingertip pelvic examination versus traditional speculum examination) (Kavoussi et al. 2009 ). Providers should also weigh the potential benefit of screening practices with their anticipated interventions should the procedure uncover new medical issues. In some situations, it is quite reasonable to forego invasive procedures if the outcome would not change a patient's decisions or a clinician's behaviour. However, given the rising life expectancy of persons with Down syndrome, it is inappropriate to ignore age-and gender-appropriate care simply because of the presence of ID.
When compared with national estimated prevalence rates of comorbidities in adults with Down syndrome (Rubin & Crocker 1989; Cooley & Graham 1991; Bell & Bhate 1992; Prasher 1995; Pueschel et al. 1995; American Academy of Pediatrics 2001; Melville et al. 2005; New York Commissioner's Task Force 2009; Steingass et al. 2011) , the individuals observed in this cohort appear to be slightly less complex on average. Our medical records indicate lower prevalence of several conditions in our cohort, with the exception of hypothyroidism, overweight/obesity and the combined measure of psychiatric disorders, behaviour difficulties, or memory regression (Fig. 3) . We hypothesise that these numbers may be artificially underestimated, as prevalence estimates in our cohort are completely dependent upon what has been documented in the medical record and not prospective evaluation. We suspect the lower numbers of persons identified with obstructive sleep apnea reflect less screening performed at our institution than is done on a national level. Additionally, care by dentists and ophthalmologists is often documented in paper charts within our health system, which were not available for review by the investigators of this study.
Limitations
This study has several limitations. First, our work reflects the experiences of patients with Down syndrome at a single tertiary care centre with multiple associated primary care clinics. This may not reflect trends in primary care practices that would be evident on a national level.
Second, the small population of patients in each of the primary care practices, especially in Internal Medicine-Pediatrics and Pediatrics, may prevent observation of true differences in care practices that would be evident within a larger cohort. However, despite the fact that the overall number of patients described in this study is not particularly large, this cohort of adults with Down syndrome is comparable in size to many previously described in the medical literature.
Third, documentation of receipt of screening domains was limited to what was recorded in the electronic medical records. This likely underestimated the domains of ophthalmology, dentistry, audiology and psychiatry, as these fields often store clinical charts outside of the electronic medical record typically utilised within this health system. Additionally, the scope of this study is to evaluate the presence or absence of screening behaviours and does not follow any subsequent interventions on the part of clinicians.
These limitations notwithstanding, we expect that the experience of caring for adults with Down syn-drome at our institution will serve as a reasonable approximation of primary care clinicians nationally. If anything, we would anticipate that the proximity to subspecialty care might artificially increase adherence rates to screening recommendations. Given the overall low adherence to preventive care recommendations observed in this study, this does not appear to be a concern.
Conclusion
Despite well-published recommendations for preventive health care in adults with Down syndrome, little is known about adherence to these guidelines. Our findings represent one of the first comparisons of primary care practices in a cohort of adults with Down syndrome.
We observed that adherence to existing preventive care guidelines was inconsistent but did not result from the 'type' of primary care each patient received (Family Medicine vs. Internal Medicine).
Rather, the patterns of incomplete adherence to Down syndrome-specific guidelines appear to mirror the discomfort in providing care for adults with ID observed in adult-oriented clinicians previously documented in the medical literature (Okumura et al. 2010; Pace et al. 2011) .
The reasons behind the inconsistent screening patterns observed in this study may serve as a reflection of several possibilities: poor documentation of issues discussed during a clinic visit, lack of awareness by the provider of existing recommendations, or more urgent medical concerns that supersede primary care discussions. In light of such findings, it is important to remember that improved screening has the potential to identify issues that can be readily treated and lead to decreased morbidity and mortality. This will allow patients and families to make more informed decisions about their care. To achieve improvements, preventive healthcare recommendations need to be widely disseminated and readily available to all primary care providers.
We hypothesise that the number and varying scope of existing preventive care recommendations for adults with Down syndrome has made it difficult for clinicians to implement many of these screening guidelines and adds confusion to already complex care management. We highlight the recommendations from the American Academy of Pediatrics (Bull & the Committee on Genetics 2011) and Steingass et al. (2011) as the most recently published high quality references for primary care physicians, and we encourage greater collaboration between stakeholders within the Down syndrome community to regularly disseminate recommendations incorporating expert opinion with evidencebased medicine. As a medical community, we need to place greater emphasis on improving the collection and storage of high-quality longitudinal data to better inform clinical guidelines. Further studies are needed to assess the implications of current screening recommendations and more timely identification of comorbidities on clinical outcomes.
